PubMed

Frequent loss of endothelin-3 (EDN3) expression due to epigenetic inactivation in human breast cancer.

Wiesmann F, Veeck J, Galm O, Hartmann A, Esteller M, Knüchel R, Dahl E.

Breast Cancer Res. 2009;11(3):R34. Epub 2009 Jun 15.PMID: 19527488 [PubMed - indexed for MEDLINE]Related articlesFree article

Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.

Veeck J, Bektas N, Hartmann A, Kristiansen G, Heindrichs U, Knüchel R, Dahl E.

Breast Cancer Res. 2008;10(5):R82. Epub 2008 Sep 30.PMID: 18826564 [PubMed - indexed for MEDLINE]Related articlesFree article

Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.

Veeck J, Noetzel E, Bektas N, Jost E, Hartmann A, Knüchel R, Dahl E.

Mol Cancer. 2008 Nov 6;7:83.PMID: 18990230 [PubMed - indexed for MEDLINE]Related articlesFree article

Epigenetic inactivation of the secreted frizzled-related protein-5 (SFRP5) gene in human breast cancer is associated with unfavorable prognosis.

Veeck J, Geisler C, Noetzel E, Alkaya S, Hartmann A, Knüchel R, Dahl E.

Carcinogenesis. 2008 May;29(5):991-8. Epub 2008 Mar 19.PMID: 18356147 [PubMed - indexed for MEDLINE]Related articlesFree article

Promoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancer.

Noetzel E, Veeck J, Niederacher D, Galm O, Horn F, Hartmann A, Knüchel R, Dahl E.

BMC Cancer. 2008 May 30;8:154.PMID: 18513385 [PubMed - indexed for MEDLINE]Related articlesFree article

Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.

Dahl E, Wiesmann F, Woenckhaus M, Stoehr R, Wild PJ, Veeck J, Knüchel R, Klopocki E, Sauter G, Simon R, Wieland WF, Walter B, Denzinger S, Hartmann A, Hammerschmied CG.

Oncogene. 2007 Aug 16;26(38):5680-91. Epub 2007 Mar 12.PMID: 17353908 [PubMed - indexed for MEDLINE]Related articles

Expression of the glioma-associated oncogene homolog (GLI) 1 in human breast cancer is associated with unfavourable overall survival.

ten Haaf A, Bektas N, von Serenyi S, Losen I, Arweiler EC, Hartmann A, Knüchel R, Dahl E.

BMC Cancer. 2009 Aug 25;9:298.PMID: 19706168 [PubMed - indexed for MEDLINE]Related articlesFree article

Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma.

Sathyanarayana UG, Padar A, Huang CX, Suzuki M, Shigematsu H, Bekele BN, Gazdar AF.

Clin Cancer Res. 2003 Dec 15;9(17):6389-94.PMID: 14695139 [PubMed - indexed for MEDLINE]Related articlesFree article

Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers.

Taniguchi H, Yamamoto H, Hirata T, Miyamoto N, Oki M, Nosho K, Adachi Y, Endo T, Imai K, Shinomura Y.

Oncogene. 2005 Nov 24;24(53):7946-52.PMID: 16007117 [PubMed - indexed for MEDLINE]Related articles

Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancer.

Veeck J, Wild PJ, Fuchs T, Schüffler PJ, Hartmann A, Knüchel R, Dahl E.

BMC Cancer. 2009 Jul 1;9:217.PMID: 19570204 [PubMed - indexed for MEDLINE]Related articlesFree article

Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis.

Veeck J, Niederacher D, An H, Klopocki E, Wiesmann F, Betz B, Galm O, Camara O, Dürst M, Kristiansen G, Huszka C, Knüchel R, Dahl E.

Oncogene. 2006 Jun 8;25(24):3479-88. Epub 2006 Jan 30.PMID: 16449975 [PubMed - indexed for MEDLINE]Related articles

Frequent epigenetic inactivation of the receptor tyrosine kinase EphA5 by promoter methylation in human breast cancer.

Fu DY, Wang ZM, Wang BL, Chen L, Yang WT, Shen ZZ, Huang W, Shao ZM.

Hum Pathol. 2010 Jan;41(1):48-58. Epub 2009 Sep 5.PMID: 19733895 [PubMed - indexed for MEDLINE]Related articles

Epigenetic suppression of secreted frizzled related protein 1 (SFRP1) expression in human breast cancer.

Lo PK, Mehrotra J, D'Costa A, Fackler MJ, Garrett-Mayer E, Argani P, Sukumar S.

Cancer Biol Ther. 2006 Mar;5(3):281-6. Epub 2006 Mar 6.PMID: 16410723 [PubMed - indexed for MEDLINE]Related articlesFree article

Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.

Jiang Y, Tong D, Lou G, Zhang Y, Geng J.

Pathobiology. 2008;75(4):244-51. Epub 2008 Jun 26.PMID: 18580070 [PubMed - indexed for MEDLINE]Related articles

The extracellular matrix protein ITIH5 is a novel prognostic marker in invasive node-negative breast cancer and its aberrant expression is caused by promoter hypermethylation.

Veeck J, Chorovicer M, Naami A, Breuer E, Zafrakas M, Bektas N, Dürst M, Kristiansen G, Wild PJ, Hartmann A, Knuechel R, Dahl E.

Oncogene. 2008 Jan 31;27(6):865-76. Epub 2007 Jul 23.PMID: 17653090 [PubMed - indexed for MEDLINE]Related articles

Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer.

Ai L, Tao Q, Zhong S, Fields CR, Kim WJ, Lee MW, Cui Y, Brown KD, Robertson KD.

Carcinogenesis. 2006 Jul;27(7):1341-8. Epub 2006 Feb 25.PMID: 16501252 [PubMed - indexed for MEDLINE]Related articlesFree article

Epigenetic mapping and functional analysis in a breast cancer metastasis model using whole-genome promoter tiling microarrays.

Rodenhiser DI, Andrews J, Kennette W, Sadikovic B, Mendlowitz A, Tuck AB, Chambers AF.

Breast Cancer Res. 2008;10(4):R62. Epub 2008 Jul 18.PMID: 18638373 [PubMed - indexed for MEDLINE]Related articlesFree article

Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis.

Cai D, Cao J, Li Z, Zheng X, Yao Y, Li W, Yuan Z.

BMC Cancer. 2009 Apr 1;9:102.PMID: 19338666 [PubMed - indexed for MEDLINE]Related articlesFree article

Methylation and gene silencing of the Ras-related GTPase gene in lung and breast cancers.

Suzuki M, Shigematsu H, Shames DS, Sunaga N, Takahashi T, Shivapurkar N, Iizasa T, Minna JD, Fujisawa T, Gazdar AF.

Ann Surg Oncol. 2007 Apr;14(4):1397-404. Epub 2006 Dec 29.PMID: 17195088 [PubMed - indexed for MEDLINE]Related articles

[Epigenetic inactivation of microRNA genes in mammary carcinoma]

Lehmann U, Hasemeier B, Römermann D, Müller M, Länger F, Kreipe H.

Verh Dtsch Ges Pathol. 2007;91:214-20. German. PMID: 18314617 [PubMed - indexed for MEDLINE]Related articles